You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RET translocation

Showing 1 - 25 of 380
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer, Cancer Metastatic, NTRK Gene Fusion Overexpression Trial in Worldwide (Data collection and quality of life

Recruiting
  • Cancer
  • +15 more
  • Data collection and quality of life questionnaire
  • Graz, Austria
  • +40 more
Jul 27, 2021

NSCLC, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (LOXO-292)

Recruiting
  • Non-Small Cell Lung Cancer
  • +3 more
  • Scottsdale, Arizona
  • +84 more
Oct 10, 2022

Nonsmall Cell Lung Cancer Trial in Shanghai (HS-10365 capsules)

Recruiting
  • Nonsmall Cell Lung Cancer
  • HS-10365 capsules
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Nov 22, 2023

Malignant Solid Tumors Trial in France (Nilotinib (400 mg BID), Everolimus (10 mg QD), Sorafenib (400 mg BID))

Recruiting
  • Malignant Solid Neoplasms
  • Nilotinib (400 mg BID)
  • +6 more
  • Bordeaux, France
  • +6 more
Dec 15, 2022

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Chang chun

Not yet recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +3 more
  • Chang chun, Jilin, China
    Jinlin Province Cancer Hosipital
Dec 21, 2022

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

Active, not recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +39 more
  • pralsetinib (BLU-667)
  • Phoenix, Arizona
  • +65 more
Nov 10, 2022

NSCLC Trial in Shanghai (SY-5007)

Recruiting
  • Non-Small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Sep 4, 2023

Advanced Solid Tumor Trial in Los Angeles (EP0031)

Recruiting
  • Advanced Solid Tumor
  • Los Angeles, California
  • +3 more
Dec 1, 2022

Refractory Solid Tumors Trial in Seoul (sunitinib)

Completed
  • Refractory Solid Tumors
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

Solid Tumor, Medullary Thyroid Cancer Trial in China (Selpercatinib)

Active, not recruiting
Has Results
  • Solid Tumor
  • Medullary Thyroid Cancer
  • Guangzhou, Guangdong, China
  • +12 more
May 9, 2022

Hematopoietic and Lymphoid Cell Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +37 more
  • Birmingham, Alabama
  • +171 more
Aug 24, 2022

MDD Trial in Ames (Resistance Exercise Training)

Active, not recruiting
  • Major Depressive Disorder
  • Resistance Exercise Training
  • Ames, Iowa
    Iowa State University
Jan 12, 2023

NSCLC, Medullary Thyroid Cancer, Solid Tumor Trial in Shanghai, Tianjin (SY-5007)

Recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Shanghai, Shanghai, China
  • +1 more
Mar 17, 2022

Stroke Trial (Power-focused resistance training)

Not yet recruiting
  • Stroke
  • Power-focused resistance training
  • (no location specified)
Apr 18, 2023

NSCLC, Thyroid Tumors Trial (LOXO-260)

Temporarily not available
  • Carcinoma, Non-Small-Cell Lung
  • Thyroid Neoplasms
  • (no location specified)
Sep 20, 2022

Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer Trial in Singapore (Oral lenvatinib + Intravenous (IV)

Not yet recruiting
  • Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer
  • Oral lenvatinib + Intravenous (IV) pembrolizumab + Oral letrozole
  • Singapore, Singapore
    National Cancer Centre Singapore
Oct 13, 2022

RET-altered Solid Tumors Trial in Shanghai (APS03118)

Recruiting
  • RET-altered Solid Tumors
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Dec 8, 2022

Macular Holes Trial in Shanghai (Translocation ILM Flap, ILM Peeling)

Recruiting
  • Macular Holes
  • Translocation ILM Flap
  • ILM Peeling
  • Shanghai, China
    Xinhua Hospital Affiliated to Shanghai Jiao Tong University Scho
Sep 25, 2023

Decompensated Cirrhosis Trial (Isomaltooligosaccharides (IMO))

Not yet recruiting
  • Decompensated Cirrhosis
  • Isomaltooligosaccharides (IMO)
  • (no location specified)
Nov 12, 2023

Secondary Sclerosis Cholangitis Prospective

Recruiting
  • Secondary Sclerosis Cholangitis in Critically Ill Patients
    • Graz, Austria
      Medical University Graz
    Sep 26, 2022

    Multiple Myeloma, Multiple Myeloma in Relapse Trial (Belantamab mafodotin, Venetoclax)

    Not yet recruiting
    • Multiple Myeloma
    • Multiple Myeloma in Relapse
    • Belantamab mafodotin, Venetoclax
    • (no location specified)
    May 10, 2023

    Thyroid Cancer, Thyroid Carcinoma, Metastatic Thyroid Cancer Trial in Boston (Selpercatinib, Sodium Iodine I-131, rhTSH)

    Not yet recruiting
    • Thyroid Cancer
    • +5 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Dec 20, 2022

    NSCLC Trial in Guangzhou (HA121-28 tablet)

    Recruiting
    • NSCLC
    • HA121-28 tablet
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Centre
    Aug 2, 2022

    Study on Dynamic CtDNA Analysis in Pediatric Soft Tissue Sarcoma

    Recruiting
    • Pediatric Soft Tissue Sarcoma
    • detection and monitoring of cirulating tumor DNA
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Mar 20, 2023

    Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET Gene Mutation Trial in Korea, Republic of, United States (TPX-0046)

    Recruiting
    • Non Small Cell Lung Cancer
    • +4 more
    • Irvine, California
    • +15 more
    Mar 9, 2022